TARDBP and proteostasis deficiencies: Several studies have shown that antibodies specific for phosphorylated S403/404 and S409/410 TDP-43 recognize TDP-43 proteinopathies in humans [17, 38] and in transgenic mice overexpressing TDP-43 [7, 24, 57].